HAIR vs. CATX, NVRO, INFU, NSPR, CTCX, HSAQ, TMDIF, GBS, RVP, and PETV
Should you be buying Restoration Robotics stock or one of its competitors? The main competitors of Restoration Robotics include Perspective Therapeutics (CATX), Nevro (NVRO), InfuSystem (INFU), InspireMD (NSPR), Carmell (CTCX), Health Sciences Acquisitions Co. 2 (HSAQ), Titan Medical (TMDIF), GBS (GBS), Retractable Technologies (RVP), and PetVivo (PETV). These companies are all part of the "medical" sector.
Restoration Robotics vs. Its Competitors
Restoration Robotics (NASDAQ:HAIR) and Perspective Therapeutics (NYSE:CATX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends.
Restoration Robotics has a net margin of -153.44% compared to Perspective Therapeutics' net margin of -4,096.66%. Perspective Therapeutics' return on equity of -27.40% beat Restoration Robotics' return on equity.
In the previous week, Restoration Robotics had 4 more articles in the media than Perspective Therapeutics. MarketBeat recorded 5 mentions for Restoration Robotics and 1 mentions for Perspective Therapeutics. Restoration Robotics' average media sentiment score of 0.00 equaled Perspective Therapeutics'average media sentiment score.
Restoration Robotics has higher revenue and earnings than Perspective Therapeutics.
17.6% of Restoration Robotics shares are owned by institutional investors. Comparatively, 54.7% of Perspective Therapeutics shares are owned by institutional investors. 37.8% of Restoration Robotics shares are owned by company insiders. Comparatively, 3.7% of Perspective Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Restoration Robotics has a beta of 4.26, suggesting that its stock price is 326% more volatile than the S&P 500. Comparatively, Perspective Therapeutics has a beta of 1.18, suggesting that its stock price is 18% more volatile than the S&P 500.
Perspective Therapeutics has a consensus price target of $12.56, suggesting a potential upside of 215.47%. Given Perspective Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Perspective Therapeutics is more favorable than Restoration Robotics.
Summary
Perspective Therapeutics beats Restoration Robotics on 7 of the 13 factors compared between the two stocks.
Get Restoration Robotics News Delivered to You Automatically
Sign up to receive the latest news and ratings for HAIR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding HAIR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Restoration Robotics Competitors List
Related Companies and Tools
This page (NASDAQ:HAIR) was last updated on 7/12/2025 by MarketBeat.com Staff